Al Anber, A.; Abu Al Karsaneh, O.; Abuquteish, D.; Abdallah, O.; Issa, M.A.; Sa’adeh, M.; Kilani, D.
Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing–Remitting Multiple Sclerosis: A Real-World Study from Jordan. Medicina 2026, 62, 203.
https://doi.org/10.3390/medicina62010203
AMA Style
Al Anber A, Abu Al Karsaneh O, Abuquteish D, Abdallah O, Issa MA, Sa’adeh M, Kilani D.
Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing–Remitting Multiple Sclerosis: A Real-World Study from Jordan. Medicina. 2026; 62(1):203.
https://doi.org/10.3390/medicina62010203
Chicago/Turabian Style
Al Anber, Arwa, Ola Abu Al Karsaneh, Dua Abuquteish, Osama Abdallah, Mohammad A. Issa, Mohammad Sa’adeh, and Dena Kilani.
2026. "Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing–Remitting Multiple Sclerosis: A Real-World Study from Jordan" Medicina 62, no. 1: 203.
https://doi.org/10.3390/medicina62010203
APA Style
Al Anber, A., Abu Al Karsaneh, O., Abuquteish, D., Abdallah, O., Issa, M. A., Sa’adeh, M., & Kilani, D.
(2026). Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing–Remitting Multiple Sclerosis: A Real-World Study from Jordan. Medicina, 62(1), 203.
https://doi.org/10.3390/medicina62010203
